Olivia Le Saux
Lyon, France
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 59 publications
Efficacy and safety of immune checkpoint inhibitor rechallenge in cervical and endometrial cancer: a multi-center retrospective study (RICE study).
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: April 23, 2026
[Corrigendum to: "French recommendations for clinical practice, Nice/Saint-Paul-de-Vence 2024-2025: Management of high-grade ovarian epithelial cancer" [Bull Cancer 2026;113:191-207]].
Journal: Bulletin du cancer
Published: April 12, 2026
FIMBRIMENOP-2402 trial: evaluating fimbriectomy with delayed oophorectomy in patients with high-risk tubo-ovarian cancer.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: April 04, 2026
Rethinking ovarian cancer III: the past decade and future directions.
Journal: Nature reviews. Cancer
Published: February 23, 2026
Concordant phase 2 evidence and biological plausibility for rare tumours.
Journal: The Lancet. Oncology
Published: January 09, 2026
French recommendations for clinical practice, Nice/Saint-Paul-de-Vence 2024-2025: Cardio-oncological management of the main therapeutic regimens in onco-gynecology
Journal: Bulletin du cancer
Published: October 24, 2025
French recommendations for clinical practice, Nice/Saint-Paul-de-Vence 2024-2025: Management of high-grade ovarian epithelial cancer
Journal: Bulletin du cancer
Published: October 23, 2025
ESMO Adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 10, 2025
ESMO adaptation of Lines of Systemic Therapy (EnLiST): a consensus framework for standardising the designation of lines of therapy in solid tumours.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: October 10, 2025
Association between molecular classification and overall survival in patients with metastatic endometrial carcinoma: ancillary results of the UTOLA phase II GINECO trial.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: August 04, 2025
HERV-derived epitopes represent new targets for T-cell-based immunotherapies in ovarian cancer.
Journal: Journal for immunotherapy of cancer
Published: July 15, 2025
Last Updated: 09/26/2026